85 related articles for article (PubMed ID: 20659164)
1. A microfluidic platform for rapid, stress-induced antibiotic susceptibility testing of Staphylococcus aureus.
Kalashnikov M; Lee JC; Campbell J; Sharon A; Sauer-Budge AF
Lab Chip; 2012 Nov; 12(21):4523-32. PubMed ID: 22968495
[TBL] [Abstract][Full Text] [Related]
2. Functional Characterisation of ClpP Mutations Conferring Resistance to Acyldepsipeptide Antibiotics in Firmicutes.
Malik IT; Pereira R; Vielberg MT; Mayer C; Straetener J; Thomy D; Famulla K; Castro H; Sass P; Groll M; Brötz-Oesterhelt H
Chembiochem; 2020 Jul; 21(14):1997-2012. PubMed ID: 32181548
[TBL] [Abstract][Full Text] [Related]
3. A new antibiotic kills pathogens without detectable resistance.
Ling LL; Schneider T; Peoples AJ; Spoering AL; Engels I; Conlon BP; Mueller A; Schäberle TF; Hughes DE; Epstein S; Jones M; Lazarides L; Steadman VA; Cohen DR; Felix CR; Fetterman KA; Millett WP; Nitti AG; Zullo AM; Chen C; Lewis K
Nature; 2015 Jan; 517(7535):455-9. PubMed ID: 25561178
[TBL] [Abstract][Full Text] [Related]
4. A putative cro-like repressor contributes to arylomycin resistance in Staphylococcus aureus.
Craney A; Romesberg FE
Antimicrob Agents Chemother; 2015; 59(6):3066-74. PubMed ID: 25753642
[TBL] [Abstract][Full Text] [Related]
5. Alanine scan of [L-Dap(2)]ramoplanin A2 aglycon: assessment of the importance of each residue.
Nam J; Shin D; Rew Y; Boger DL
J Am Chem Soc; 2007 Jul; 129(28):8747-55. PubMed ID: 17592838
[TBL] [Abstract][Full Text] [Related]
6. An extensively validated whole-cell biosensor for specific, sensitive and high-throughput detection of antibacterial inhibitors targeting cell-wall biosynthesis.
Galarion LH; Mitchell JK; Randall CP; O'Neill AJ
J Antimicrob Chemother; 2023 Mar; 78(3):646-655. PubMed ID: 36626387
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic convergence of bacterial adaption to sub-lethal antibiotic treatment.
Wee GN; Lyou ES; Hong JK; No JH; Kim SB; Lee TK
Front Cell Infect Microbiol; 2022; 12():913415. PubMed ID: 36467735
[TBL] [Abstract][Full Text] [Related]
8.
Poshvina DV; Dilbaryan DS; Kasyanov SP; Sadykova VS; Lapchinskaya OA; Rogozhin EA; Vasilchenko AS
Front Microbiol; 2022; 13():963979. PubMed ID: 36246291
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Resistance Phenotype of
Jaja IF; Jaja CI; Chigor NV; Anyanwu MU; Maduabuchi EK; Oguttu JW; Green E
Biomed Res Int; 2020; 2020():3979482. PubMed ID: 33015163
[TBL] [Abstract][Full Text] [Related]
10. Production of Ramoplanin and Ramoplanin Analogs by Actinomycetes.
de la Cruz M; González I; Parish CA; Onishi R; Tormo JR; Martín J; Peláez F; Zink D; El Aouad N; Reyes F; Genilloud O; Vicente F
Front Microbiol; 2017; 8():343. PubMed ID: 28321210
[TBL] [Abstract][Full Text] [Related]
11. Envelope Structures of Gram-Positive Bacteria.
Rajagopal M; Walker S
Curr Top Microbiol Immunol; 2017; 404():1-44. PubMed ID: 26919863
[TBL] [Abstract][Full Text] [Related]
12. Novel formulations for antimicrobial peptides.
Carmona-Ribeiro AM; de Melo Carrasco LD
Int J Mol Sci; 2014 Oct; 15(10):18040-83. PubMed ID: 25302615
[TBL] [Abstract][Full Text] [Related]
13. Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria.
Bionda N; Pitteloud JP; Cudic P
Future Med Chem; 2013 Jul; 5(11):1311-30. PubMed ID: 23859209
[TBL] [Abstract][Full Text] [Related]
14. Bacterial cell surface deformation under external loading.
Chen Y; Norde W; van der Mei HC; Busscher HJ
mBio; 2012 Dec; 3(6):. PubMed ID: 23249811
[TBL] [Abstract][Full Text] [Related]
15. Generation of ramoplanin-resistant Staphylococcus aureus.
Schmidt JW; Greenough A; Burns M; Luteran AE; McCafferty DG
FEMS Microbiol Lett; 2010 Sep; 310(2):104-11. PubMed ID: 20659164
[TBL] [Abstract][Full Text] [Related]
16. Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus.
Cheng M; Huang JX; Ramu S; Butler MS; Cooper MA
Antimicrob Agents Chemother; 2014 Nov; 58(11):6819-27. PubMed ID: 25182650
[TBL] [Abstract][Full Text] [Related]
17. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Brumfitt W; Salton MR; Hamilton-Miller JM
J Antimicrob Chemother; 2002 Nov; 50(5):731-4. PubMed ID: 12407132
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of vancomycin, teicoplanin, ramoplanin (formerly A16686), paldimycin, DuP 721 and DuP 105 against methicillin and gentamicin resistant Staphylococcus aureus.
Maple PA; Hamilton-Miller JM; Brumfitt W
J Antimicrob Chemother; 1989 Apr; 23(4):517-25. PubMed ID: 2526111
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
